Company Info
Phone(707) 523-1950
Year Established
2020
Ticker
JNJ
Exchange
NYSE
Contacts
Randy LashinskiPresident & CEO
Josh Dwork
Director, R&D
Michael Lee
Director of Operations
Company Description
LAMINAR, a JnJ company, is a device company eliminating the left atrial appendage (LAA) in patients with non-valvular atrial fibrillation.
